Novartis AG

Switzerland


 
Total IP 11,297
Total IP incl. subs 19,576 (+ 8,685 for subs)
Total IP Rank # 72
IP Activity Score 4.3/5.0    5,187
IP Activity Rank # 108
IP AS incl. subs 4.3/5.0    8,788
Stock Symbol
ISIN US66987V1098
Market Cap. 190,200M  (USD)
Industry Drug Manufacturers - Major
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

1,802 1,241
720 691
3,638 2,065
1,140
 
Last Patent 2024 - Anti-ccr7 antibody drug conjugates
First Patent 1973 - O-substituted 7.beta.-amino-3-ce...
Last Trademark 2024 - ORBIT
First Trademark 1942 - METHERGINE

Subsidiaries

98 subsidiaries with IP (5924 patents, 2761 trademarks)

70 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Ophthalmic surgery devices and instruments for controlled sub-retinal delivery of pharmaceutical,...
G/S Pharmaceutical preparations.
G/S Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep...
G/S Pharmaceutical and medical preparations; sanitary preparations for medical purposes; pharmaceutic...
G/S Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa...
G/S Pharmaceutical preparations for the prevention and treatment of the central nervous system, namel...
G/S Pharmaceutical preparations and gene therapy products in the nature of injectable biologic prepar...
G/S Préparations pharmaceutiques pour le diagnostic et le traitement de maladies et de troubles oncol...
G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...
G/S Providing access to an electronic exchange of medical records across a nationwide health informat...
G/S Pharmaceutical preparations and gene therapy products in the nature of injectable biologic prepa...
2023 G/S Incubators for laboratory use
G/S Incubators for laboratory use.
G/S Pharmaceutical preparations. Computer software; Computer application (software); computer softwa...
G/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;...
G/S Downloadable software for the facilitation of communication, namely, allowing patients and health...
G/S Non-medicated cosmetics; cosmetic preparations for the skin; cosmetic gels, creams and lotions; e...
Invention Combination therapy for the treatment of cancer. The present disclosure relates to a pharmaceuti...
Invention Drug delivery systems. The present invention relates to thermogelling peptide delivery systems w...
Invention Treatment of autoimmune disorders using chimeric antigen receptor therapy. The invention provides...
Invention Methods of making chimeric antigen receptor-expressing cells. The invention provides methods of ...
Invention Amorphous solid dispersions comprising naporafenib. The present invention relates to the field of...
Invention Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis. The present ...
Invention Nlrp3 inflammasome inhibitors. The present invention relates to novel pyridazin-3-yl phenol compo...
Invention Nlrp3 inflammasome inhibitors. The present invention relates to novel pyridazin-3-yl phenol comp...
Invention Compounds and compositions for treating solid tumors by intratumoral administration. The inventi...
Invention Treatment for acute organ injury using cd39, recombinant cd39. The present invention pertains to ...
Invention Improved production of cd39 variants. The present invention pertains to the use of miRNA technolo...
Invention Dosing regimen for a nlrp3 inhibitor. The present disclosure relates to the field of pharmacy, pa...
Invention Pharmaceutical compositions of tricyclic akr1c3 dependent kars inhibitor and methods for making s...
Invention Crystalline forms of an akr1c3 dependent kars inhibitor. This application relates to crystalline ...
Invention Methods of tricyclic akr1c3 dependent kars inhibitor dosing field of the invention. The present i...
Invention Treatment of aiha with baff or baff receptor inhibitory antibodies. The disclosure relates to a m...
Invention Novel fatty acids and their use in conjugation to biomolecules. The invention provides a conjuga...
Invention Patient onboarding and autoinjector integration. Systems and processes for guiding a user through...
Invention Methods for treating hematologic cancers. The present invention relates to methods of treating h...
Invention 1,4-disubstituted pyridazine quinolne analogs there of and methods for treating smn-deficiency-re...
Invention Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof. The present...
Invention Octreotide depot formulation with constantly high exposure levels. The present invention relates...
Invention Use of canakinumab. The present invention relates to canakinumab for use in reducing the risk of...
Invention Car t cell therapies with enhanced efficacy. The invention provides methods for manufacturing op...
Invention Methods of using il-1beta compounds. This invention relates to methods employing IL-1 beta-ligan...
Invention Anti-ccr7 antibody drug conjugates. This application discloses anti-CCR7 antibodies, antigen bin...
Invention Factor xi antibodies and methods of use. The present invention relates to monoclonal antibodies ...
2022 Invention Pyrrolopyrimidine compounds and their uses. The disclosed compounds relate to treatments and the...
Invention Combination therapies. Combination therapies are disclosed. The combination therapies can be use...
Invention Compositions and methods to treat cancer. The disclosure provides novel personalized therapies, ...
Invention Dosing regimens for sars-cov-2 binding molecules. The instant disclosure relates to compositions ...
Invention Nucleic acid molecules encoding chimeric antigen receptors comprising a cd20 binding domain. The ...
2021 Invention Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor fo...
Invention Pyrrolo[3,2-b]pyridine derivatives useful in treating conditions associated with cgas. The prese...
Invention Radiolabelled alpha-v beta-3 and/or alpha-v beta-5 integrins antagonist for use as theragnostic a...
Invention Reversal binding agents for anti-natriuretic peptide receptor i (npri) antibodies and uses thereo...
Invention Use of mglur5 antagonists for treating gambling disorder. The present invention relates to the u...
Invention Use of mglur5 antagonists for treating amphetamine addiction. The invention relates to the mavog...
Invention Dosage regimen for a nr2b-nmda receptor nam for the treatment of depression. The invention relat...
Invention Mcl-1 inhibitor antibody-drug conjugates and methods of use. Anti-CD48 antibody-drug conjugates ...
Invention Synthesis of prostate specific membrane antigen (psma) ligands. The present disclosure relates t...
Invention Combination therapies with chimeric antigen receptor (car)-expressing cells. This disclosure pro...
Invention Cd19 binding molecules and uses thereof. The present disclosure provides CD19 binding molecules ...
Invention Use of an erk inhibitor for the treatment of myelofibrosis. The invention relates to the use of ...
Invention Treatments for retinal degenerative diseases. Methods for treating or improving a retinal degene...
2020 Invention Methods for measuring cralbp activity. The present disclosure provides methods for measuring act...
Invention Methods for treating ocular diseases. A method is provided for treating a patient having a neova...